Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Hepatitis A
Safety Administration Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Parents/caregivers Mumps Measles Rubella
Adolescents (10-18 years) Adults (18+) vaccine safety Agenda & Minutes United States of America Herpes zoster Influenza Mumps Human papillomavirus (HPV) Japanese encephalitis Pneumococcal disease
Download:
Agenda & Minutes Germany Herpes zoster Hepatitis A Hepatitis B Influenza Tetanus Diphtheria Poliomyelitis
Download:
immunodeficiency Agenda & Minutes Germany Influenza Hepatitis A Hepatitis B Human papillomavirus (HPV) Herpes zoster
Download:
Agenda & Minutes United States of America Hepatitis A
Download:
Recommendation Germany Hepatitis A
Download: